abrdn Life Sciences Investors (NYSE:HQL) Announces Quarterly Dividend of $1.50

abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Tuesday, November 10th. Shareholders of record on Friday, November 20th will be paid a dividend of $1.50 per share on Tuesday, January 12th. This represents a $6.00 annualized dividend and a yield of 31.7%. The ex-dividend date is Friday, November 20th.

abrdn Life Sciences Investors Trading Up 1.4%

Shares of NYSE HQL traded up $0.26 during mid-day trading on Wednesday, hitting $18.93. 77,995 shares of the stock traded hands, compared to its average volume of 127,762. The firm has a 50 day simple moving average of $18.62 and a two-hundred day simple moving average of $18.28. abrdn Life Sciences Investors has a twelve month low of $15.66 and a twelve month high of $22.67.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors is a non-diversified, closed-end investment fund focused on companies in the life sciences and health care sectors. Rather than developing or selling products itself, the fund invests in businesses involved in areas such as biotechnology, pharmaceuticals, medical devices and related services. The fund seeks long-term capital appreciation through a portfolio that can include both publicly traded and privately held companies. Its investments may span U.S. and international markets.